Trial intelligence / Profile preview

Fiber Reinforced Bulk Fill vs Incremental Nanohybrid in Deep Proximal Lesions

NCT04019145Phase 1Completed

Sponsor
Cairo University
Start
Sep 2020
Primary completion
Sep 2021
Countries
1
01

Overview

Phase 1, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Mechanical outcome according to USPHS criteria at 12 months. Started Sep 2020; status: completed.

Beyond the preview

Go deeper on NCT04019145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04019145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call